SEBASTIANI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.960
EU - Europa 24.084
AS - Asia 11.437
SA - Sud America 1.750
AF - Africa 263
OC - Oceania 110
Continente sconosciuto - Info sul continente non disponibili 26
Totale 64.630
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.475
IT - Italia 13.874
GB - Regno Unito 4.166
CN - Cina 3.717
SG - Singapore 3.524
HK - Hong Kong 1.597
BR - Brasile 1.357
SE - Svezia 1.329
DE - Germania 850
UA - Ucraina 627
FR - Francia 612
VN - Vietnam 593
RU - Federazione Russa 566
FI - Finlandia 510
TR - Turchia 489
NL - Olanda 471
KR - Corea 333
ID - Indonesia 248
BG - Bulgaria 243
JP - Giappone 229
IN - India 224
CA - Canada 206
MX - Messico 203
IE - Irlanda 202
AR - Argentina 155
PL - Polonia 107
AU - Australia 100
ZA - Sudafrica 96
CH - Svizzera 78
LT - Lituania 68
ES - Italia 61
EC - Ecuador 56
PK - Pakistan 54
IQ - Iraq 53
BD - Bangladesh 52
BE - Belgio 51
RO - Romania 51
TN - Tunisia 51
AT - Austria 48
CL - Cile 47
MY - Malesia 44
IR - Iran 41
CO - Colombia 39
EG - Egitto 33
BZ - Belize 31
SA - Arabia Saudita 31
AE - Emirati Arabi Uniti 29
PE - Perù 28
VE - Venezuela 27
MA - Marocco 25
PT - Portogallo 25
JO - Giordania 23
TH - Thailandia 23
EU - Europa 21
KE - Kenya 19
TW - Taiwan 19
HU - Ungheria 18
PH - Filippine 18
CZ - Repubblica Ceca 16
DK - Danimarca 15
GR - Grecia 15
PY - Paraguay 15
UZ - Uzbekistan 15
IL - Israele 14
UY - Uruguay 13
AL - Albania 12
LV - Lettonia 12
DZ - Algeria 11
AZ - Azerbaigian 10
BO - Bolivia 10
NO - Norvegia 10
NP - Nepal 10
NZ - Nuova Zelanda 10
LU - Lussemburgo 9
DO - Repubblica Dominicana 8
RS - Serbia 8
HN - Honduras 7
HR - Croazia 7
BY - Bielorussia 6
KG - Kirghizistan 6
KW - Kuwait 6
LB - Libano 6
OM - Oman 6
PA - Panama 6
JM - Giamaica 5
TT - Trinidad e Tobago 5
MD - Moldavia 4
QA - Qatar 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
CY - Cipro 3
ET - Etiopia 3
GY - Guiana 3
KZ - Kazakistan 3
LK - Sri Lanka 3
MK - Macedonia 3
NI - Nicaragua 3
UG - Uganda 3
AM - Armenia 2
Totale 64.584
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.866
Southend 2.843
Fairfield 2.496
Singapore 2.379
Ashburn 1.893
Hong Kong 1.570
Chandler 1.403
Woodbridge 1.391
Hefei 1.383
Houston 1.146
Milan 1.049
Jacksonville 944
Rome 944
Wilmington 893
Seattle 886
Chicago 866
Ann Arbor 783
Cambridge 781
London 730
Nyköping 687
Los Angeles 670
Dearborn 669
Beijing 514
Salt Lake City 384
Modena 369
Helsinki 322
New York 299
Seoul 284
The Dalles 262
San Diego 261
Florence 251
Bologna 244
Izmir 244
Princeton 234
Sofia 233
Naples 224
Council Bluffs 199
Turin 193
Redwood City 189
Ho Chi Minh City 187
Jakarta 187
Dallas 186
Eugene 182
Moscow 182
Palermo 178
Bari 174
Tampa 172
Elk Grove Village 162
Shanghai 160
Buffalo 156
Dublin 150
Hanoi 149
Genoa 133
Des Moines 132
São Paulo 132
Catania 116
Verona 113
Bremen 111
Tokyo 108
San Jose 102
Padova 99
Cagliari 98
Columbus 95
Frankfurt am Main 92
Falls Church 91
Sterling 87
Boardman 76
Munich 75
Brescia 73
Guangzhou 67
Lancaster 67
Atlanta 63
Kent 63
Parma 62
Mexico City 61
Brooklyn 56
Redondo Beach 55
Detroit 53
Toronto 53
Miami 50
Dulles 49
Manchester 49
Monza 49
Perth 47
Warsaw 47
Salerno 46
Bergamo 45
Norwalk 44
Phoenix 44
Messina 42
Denver 41
Perugia 41
Nuremberg 39
Pisa 39
Dong Ket 38
Montreal 38
Orem 38
Reggio Emilia 38
Johannesburg 37
Belo Horizonte 36
Totale 39.433
Salva come PNG Salva come JPEG
Nome #
Prevalenza delle epatiti nelle malattie reumatiche 6.667
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.730
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.237
TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI 1.201
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 872
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 735
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 507
Semeiotica dell'articolazione temporo-mandibolare 494
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 408
B-cells and mixed cryoglobulinemia 402
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 391
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 391
Capillaroscopia del letto periungueale in pazienti affetti da artrite psoriasica e spondilite anchilosante. 372
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 363
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 359
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 351
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 350
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 350
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 345
Thymus alterations and systemic sclerosis 341
Validation of the classification criteria for cryoglobulinaemic vasculitis 336
Heart involvement and systemic sclerosis 332
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 329
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 329
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 329
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 328
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 316
Current treatment of hepatitis C-associated rheumatic diseases. 310
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 310
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 309
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 306
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 306
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 305
Aortic pulse wave velocity measurement in systemic sclerosis patients. 304
Cardiac Involvement in Systemic Vasculitis 303
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 302
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 301
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 300
L-Arginine in pregnant scleroderma patients 300
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 294
Elevated Troponin Serum Levels in Adult Onset Still's Disease 287
HCV and cryoglobulinemic vasculitis. 282
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 281
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 280
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 280
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 278
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 277
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 276
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 275
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 274
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 273
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 273
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry. 273
Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent? 268
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 266
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 264
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 263
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 259
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 258
Cardiovascular risk and prostanoids in systemic sclerosis 252
Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection 251
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 251
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 248
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 247
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 243
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 242
EFFICACIA, SAFETY E TOLLERANZA DI ADALIMUMAB IN PRIMA E SECONDA LINEA IN PAZIENTI CON ARTRITE REUMATOIDE: ESPERIENZA DAI REGISTRI ITALIANI DEI FARMACI BIOLOGICI 241
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 241
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 240
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 240
New targeted molecular therapies for dedifferentiated thyroid cancer 238
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 237
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 236
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 235
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 235
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 233
The Expanding Spectrum of Clinical Features in HCV-Related Mixed Cryoglobulinemia 232
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement 232
Systemic sclerosis following human cytomegalovirus infection 230
HCV-related rheumatic manifestations and therapeutic strategies 230
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 229
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 228
Acute exacerbation of interstitial lung disease associated with rheumatic disease 228
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 226
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 222
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report. 222
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 222
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 222
Treatment of HCV-related mixed cryoglobulinemia 221
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 219
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection 217
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 216
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 215
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 215
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 215
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 215
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 214
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 213
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 213
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 213
Totale 40.721
Salva come PNG Salva come JPEG
Categoria #
all - tutte 248.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 248.020
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.882 0 0 0 0 0 552 593 795 400 645 426 471
2021/20225.162 278 415 377 408 239 423 271 312 585 472 748 634
2022/20237.737 676 522 436 487 804 957 523 753 945 354 745 535
2023/20247.596 470 503 547 790 1.025 553 653 868 294 485 599 809
2024/202513.591 705 370 449 972 2.413 1.779 920 700 1.426 881 1.393 1.583
2025/202613.171 1.347 916 1.897 3.068 4.300 1.643 0 0 0 0 0 0
Totale 65.284